Loading...

Atai Life Sciences N.V.

ATAI•NASDAQ
Healthcare
Biotechnology
$3.57
$-0.17(-4.55%)

Atai Life Sciences N.V. (ATAI) AI-Powered Stock Analysis

See how Atai Life Sciences N.V. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Atai Life Sciences N.V. (ATAI) Stock Overall Grade

Atai Life Sciences N.V.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Atai Life Sciences N.V.'s overall stock rating.

Forecast

C+

Score

55/100

Financial Growth

B

Score

60/100

Fundamental Growth

C

Score

44/100

Key Ratios

C+

Score

55/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

B+

Score

75/100

Atai Life Sciences N.V. (ATAI) AI-Powered Stock Analysis

This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (44/100, C) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.

Component Analysis Explained

Understand the key factors behind each Atai Life Sciences N.V. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;